Tianjin Ringpu Bio-Technology Co.,Ltd. Stock

Stocks

300119

CNE100000TV1

Pharmaceuticals

End-of-day quote Shenzhen S.E. 2026-07-15 5-day change 1st Jan Change
16.29 CNY +1.62% Intraday chart for Tianjin Ringpu Bio-Technology Co.,Ltd. +3.56% -13.21%

Valuation: Tianjin Ringpu Bio-Technology Co.,Ltd.

Market Cap 7.4B 1.09B 953M 879M 806M 1.53B 105B 1.56B 10.48B 4.11B 51.41B 4.11B 4.02B 177B P/E 2026 *
16.7x
P/E 2027 * 14.4x
Enterprise Value 7.92B 1.17B 1.02B 941M 863M 1.64B 113B 1.67B 11.21B 4.4B 55.02B 4.4B 4.3B 190B EV / Sales 2026 *
2.1x
EV / Sales 2027 * 1.82x
Free-Float
51.96%
Yield 2026 *
1.84%
Yield 2027 * 2.97%
06-09 Tianjin Ringpu Bio-Technology Co.,Ltd. signed an Equity Transfer Agreement to acquire an additional 30% stake in Tianjin Zhongrui Supply Chain Management Co., Ltd. from Ringpai National Chain Veterinary Hospital Management Co., Ltd. for CNY 65.9 million. CI
04-27 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
03-30 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
03-29 Tianjin Ringpu Bio-Technology Co.,Ltd. announces Annual dividend, payable on May 13, 2026 CI
03-26 Tianjin Ringpu Bio-Technology Co.,Ltd. announced that it expects to receive CNY 300 million in funding CI
11-27 Ringpu Bio-Technology Secures Registration For Feline Vaccine MT
25-10-29 Maxhealth Biotech Co. Ltd. announced that it has received CNY 400 million in funding from IDG Ventures, Shenzhen Capital Group Co., Ltd., Tianjin Ringpu Bio-Technology Co.,Ltd. CI
25-10-24 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025 CI
25-08-25 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025 CI
25-07-14 Ringpu Bio-Tech Forecasts Up to 70% Rise in H1 Profit MT
25-06-13 Jiangxi Twins Biotechnology Co., Ltd signed a letter of intent to acquire 67.18% stake in Hunan Sinoland Bio-Pharmacy Co., Ltd. from Tianjin Ringpu Bio-Technology Co.,Ltd. and Jingpeng Holding Group Co., Ltd for approximately CNY 115 million. CI
25-04-30 Tranche Update on Tianjin Ringpu Bio-Technology Co.,Ltd.'s Equity Buyback Plan announced on November 4, 2024. CI
25-04-29 Tianjin Ringpu Bio-Technology Co.,Ltd.'s Equity Buyback announced on November 4, 2024, has closed with 6,997,751 shares, representing 1.52% for CNY 129.98 million. CI
1 day+1.62%
1 week+3.56%
Current month+12.89%
1 month+3.04%
3 months-11.13%
6 months-18.18%
Current year-13.21%
1 week 15.21
Extreme 15.21
16.45
1 month 13.91
Extreme 13.91
16.45
Current year 13.91
Extreme 13.91
21.51
1 year 13.91
Extreme 13.91
24.03
3 years 11.25
Extreme 11.25
28.9
5 years 11.25
Extreme 11.25
31.33
10 years 6.3
Extreme 6.3
44.41
Manager TitleAgeSince
Chief Executive Officer 53 2023-03-29
Director of Finance/CFO 51 2022-04-27
Corporate Officer/Principal 45 2020-10-26
Director TitleAgeSince
Chairman 63 2008-05-11
Director/Board Member 53 2019-12-24
Director/Board Member 51 2020-01-09
Date Insider Type Main position Quantity % Market Cap.
06-15Buy

Chief Executive Officer

500,000 0.1535%
23-05-23Buy 3,000 0.0009%
23-05-22Buy 1,000 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
+1.62%+3.56%-17.93%-11.85% 1.07B
+0.62%-2.31%-52.12%-56.72% 31.05B
-0.04%+3.65%+71.52%+115.71% 12.76B
-0.88%-1.99%-19.49%-1.62% 3.62B
-0.62%-1.99%-6.30%+25.98% 3.09B
+2.52%-3.33%+55.34%+27.99% 1.92B
+2.11%+4.48%-25.53%+20.41% 1.69B
+2.12%+1.87%+6.98%+131.41% 1.34B
+0.97%+0.14%-7.98%-18.79% 956M
+4.32%+6.54%-13.76%-44.89% 942M
Average +1.27%+1.63%-0.93%+18.76% 5.84B
Weighted average by Cap. +0.54%-0.47%-13.05%-0.32%

Financials

2026 *2027 *
Net sales 3.77B 558M 485M 448M 411M 781M 53.66B 796M 5.34B 2.09B 26.19B 2.09B 2.05B 90.39B 4.26B 630M 549M 506M 464M 883M 60.66B 900M 6.03B 2.37B 29.6B 2.37B 2.31B 102B
Net income 441M 65.27M 56.81M 52.4M 48.09M 91.44M 6.28B 93.15M 625M 245M 3.07B 245M 240M 10.58B 527M 78.04M 67.93M 62.66M 57.5M 109M 7.51B 111M 747M 293M 3.67B 293M 287M 12.65B
Net Debt 519M 76.85M 66.9M 61.7M 56.62M 108M 7.4B 110M 736M 289M 3.61B 289M 282M 12.46B 337M 49.87M 43.4M 40.04M 36.74M 69.86M 4.8B 71.17M 477M 187M 2.34B 187M 183M 8.08B
Logo Tianjin Ringpu Bio-Technology Co.,Ltd.
Tianjin Ringpu Bio-Technology Co Ltd is a China-based company serving the animal health industry. The Company's main business areas are the research and development, production and sales of veterinary biological products, veterinary pharmaceutical preparations (chemicals, traditional Chinese veterinary medicines, disinfectants, and others), veterinary raw materials, veterinary functional additives, and provision of overall prevention and control of animal diseases. The Company's products include pharmaceuticals, vaccines, disinfectants, cleaning agents, and functional additives for pigs, chickens, waterfowl, cattle, sheep and pets, and others.
Employees
2,803
Date Price Change Volume
26-07-15 CN¥16.29 +1.62% 4,549,179
26-07-14 CN¥16.03 +1.52% 4,804,000
26-07-13 CN¥15.79 +1.41% 5,559,200
26-07-10 CN¥15.57 +1.57% 3,680,700
26-07-09 CN¥15.33 -2.97% 4,278,400
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
16.29CNY
Average target price
20.41CNY
Spread / Average Target
+25.29%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 300119 Stock